Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAC vs ECF in Unknown Primary Carcinoma
NCT00022178Phase 3Unknown
- Sponsor
- The Christie
- Start
- Dec 1998
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vincristine, doxorubicin, cyclophosphamide, epirubicin, cisplatin in carcinoma of unknown primary (CUP), sponsored by The Christie. Status: unknown.
02
Drugs
vincristinedoxorubicincyclophosphamideepirubicincisplatin
03
Conditions
carcinoma of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00022178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022178.